Dr. Lyudmila V. Dergunova
Biography & Research Background
Lyudmila V. Dergunova is affiliated with the Institute of Molecular Genetics, Russian Academy of Sciences, and the National Research Center Kurchatov Institute. She has conducted genome-wide transcriptional analyses that uncovered the molecular mechanisms of Semax, highlighting its effects on immune and vascular gene expression during ischemia. Her work established that Semax activates the transcription of neurotrophins and their receptors in the brain following cerebral occlusion. Lyudmila V. Dergunova is being referenced as one of the leading scientists involved in the research and development of Semax. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of this product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure US Peptide and this doctor.
External Profiles
Authored Research Profiles (1)
Dr. Lyudmila V. Dergunova is referenced as a leading researcher in the following peptide research profiles on Pure U.S. Peptides:
Dr. Lyudmila V. Dergunova is being referenced as one of the leading scientists involved in the research and development of the peptides listed above. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of any product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure U.S. Peptides and this researcher. The purpose of citing the researcher is to acknowledge, recognize, and credit the exhaustive research and development efforts conducted by the scientists studying these peptides.